• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension.

作者信息

Stanley A J, Gilmour H M, Ghosh S, Ferguson A, McGilchrist A J

机构信息

Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Scotland.

出版信息

Gastroenterology. 1996 Dec;111(6):1679-82. doi: 10.1016/s0016-5085(96)70033-1.

DOI:10.1016/s0016-5085(96)70033-1
PMID:8942750
Abstract

A case of a 41-year-old man with diarrhea, hypoalbuminemia, and cryptogenic cirrhosis with features of portal hypertension is described. Protein-losing enteropathy was confirmed by analysis of whole-gut lavage fluid, and intestinal inflammation and infection were excluded. Distal duodenal biopsy specimens showed evidence of edematous villi with prominent submucosal vascular and lymphatic vessels. A transjugular intrahepatic portosystemic stent-shunt was inserted, resulting in resolution of both his diarrhea and elevated whole gut lavage fluid protein concentrations. His symptoms recurred and then again improved after shunt thrombosis and parallel shunt placement, respectively. Histological improvement of the villous edema was also noted. This is the first recorded case of protein-losing enteropathy caused by portal hypertension confirmed by successful treatment with transjugular intrahepatic portosystemic stent-shunt.

摘要

相似文献

1
Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension.
Gastroenterology. 1996 Dec;111(6):1679-82. doi: 10.1016/s0016-5085(96)70033-1.
2
Is protein-losing enteropathy a significant complication of portal hypertension?蛋白丢失性肠病是门静脉高压的一种严重并发症吗?
Am J Gastroenterol. 1998 Jan;93(1):127-8. doi: 10.1111/j.1572-0241.1998.127_c.x.
3
[Hemolytic anemia secondary to the placement of a portosystemic stented shunt].[门静脉系统支架分流术后继发溶血性贫血]
Cir Cir. 2013 Mar-Apr;81(2):143-7.
4
The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.经颈静脉肝内门体分流术对全身心脏循环参数的影响。
J Crit Care. 2014 Dec;29(6):1001-5. doi: 10.1016/j.jcrc.2014.06.028. Epub 2014 Aug 16.
5
Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.经颈静脉肝内门体分流术治疗布加综合征
Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1151-4. doi: 10.1097/01.meg.0000236874.75601.a1.
6
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation.经颈静脉肝内门体分流术治疗伴或不伴海绵样变性的门静脉血栓形成
Aliment Pharmacol Ther. 2006 Mar 15;23(6):767-75. doi: 10.1111/j.1365-2036.2006.02820.x.
7
Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines?经颈静脉肝内门体分流术(TIPS)治疗门静脉高压症的新问题:是时候更新指南了吗?
Dig Liver Dis. 2010 Jul;42(7):462-7. doi: 10.1016/j.dld.2009.11.007. Epub 2009 Dec 29.
8
Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.原位肝移植术后不明原因门静脉高压早期复发患者行经颈静脉肝内门体分流术置入支架。
Z Gastroenterol. 1998 Feb;36(2):159-64.
9
[Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].经颈静脉肝内门体分流术联合Viatorr覆膜支架植入术:3例报告
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):294-6.
10
Treatment of Budd-Chiari syndrome by transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术治疗布加综合征
Hepatogastroenterology. 2007 Sep;54(78):1813-6.

引用本文的文献

1
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.失代偿期肝硬化的营养不良和肌肉减少症相关门静脉高压症的发病机制、影响及治疗机会
Nutrients. 2023 Dec 21;16(1):35. doi: 10.3390/nu16010035.
2
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients.经颈静脉肝内门体分流术的置入:对肝硬化患者营养状况的影响
J Clin Med. 2023 Nov 10;12(22):7029. doi: 10.3390/jcm12227029.
3
Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications.
晚期肝硬化中的淋巴功能障碍:背景视角与临床意义
World J Hepatol. 2021 Mar 27;13(3):300-314. doi: 10.4254/wjh.v13.i3.300.
4
Intestinal Lymphangiectasia Associated With Refractory Ascites in a Cirrhosis Patient.一名肝硬化患者中与难治性腹水相关的肠淋巴管扩张症
Cureus. 2021 Jan 7;13(1):e12567. doi: 10.7759/cureus.12567.
5
Changes of Intestinal Functions in Liver Cirrhosis.肝硬化患者肠道功能的变化
Inflamm Intest Dis. 2016 Apr;1(1):24-40. doi: 10.1159/000444436. Epub 2016 Mar 8.
6
Nutritional Therapy in Liver Transplantation.肝移植中的营养治疗。
Nutrients. 2017 Oct 16;9(10):1126. doi: 10.3390/nu9101126.
7
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.蛋白丢失性肠病:与临床和亚临床疾病状态的机制关联的全面综述
Clin Exp Gastroenterol. 2017 Jul 17;10:147-168. doi: 10.2147/CEG.S136803. eCollection 2017.
8
Protein-losing Enteropathy Caused by Intestinal or Colonic Lymphangiectasia Complicated by Sporadic Lymphangioleiomyomatosis: A Report of Two Cases.肠道或结肠淋巴管扩张症合并散发性淋巴管平滑肌瘤病所致蛋白丢失性肠病:两例报告
Intern Med. 2017;56(8):943-948. doi: 10.2169/internalmedicine.56.7769. Epub 2017 Apr 15.
9
Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.人血清白蛋白稳态:对合成、分解代谢、肾脏和胃肠道排泄作用的新认识以及血清白蛋白测量的临床价值。
Int J Gen Med. 2016 Jul 15;9:229-55. doi: 10.2147/IJGM.S102819. eCollection 2016.
10
Nutrition therapy: Integral part of liver transplant care.营养治疗:肝移植护理的重要组成部分。
World J Gastroenterol. 2016 Jan 28;22(4):1513-22. doi: 10.3748/wjg.v22.i4.1513.